Abridge vs Nabla: Two AI Medical Scribes, Different Target Markets
Start with NoPajamaTime's free 24-hour proof to create and review one note.
NoPajamaTime creates a draft outside the EHR. The clinician reviews it, copies only permitted narrative text into an appropriate EHR field, completes structured work separately, and signs inside the EHR. Universal native EHR write-back is not claimed.
Both generate clinical notes from physician-patient conversations. But they were built for different customers, different geographies, and different deployment models.
Abridge: US Health System Focus
Abridge's public materials emphasize partnerships with major US health systems, including UPMC and Kaiser Permanente, along with investment in clinical accuracy and physician-satisfaction research. Its public offering is oriented toward institutional deployment. Independent physicians should verify current direct-access options with Abridge.
Nabla: More Individual Access
Nabla originated in Europe and has offered more individual-accessible plans than most enterprise AI scribes. They've expanded into the US market. Physicians looking for individual access to an AI scribe should check Nabla's current US pricing and plan availability directly — it has changed as they've grown.
Abridge
Nabla
Built specifically for US independent practice
NoPajamaTime was built for independent US physicians — solo, small group, DPC, and concierge. Start with the free 24-hour proof to create and review one note. The clinician reviews the draft and copies permitted narrative text into the existing EHR; universal native EHR write-back is not claimed.